本頁面由Tiger Trade Technology Pte. Ltd.提供服務

C4 Therapeutics, Inc.

4.01
+0.00500.12%
成交量:95.26萬
成交額:370.41萬
市值:4.93億
市盈率:-4.41
高:4.03
開:3.97
低:3.81
收:4.00
52周最高:5.17
52周最低:1.69
股本:1.23億
流通股本:9,451.50萬
量比:0.64
換手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-0.9085
每股收益(LYR):-1.2666
淨資產收益率:-48.14%
總資產收益率:-19.25%
市淨率:1.99
市盈率(LYR):-3.16

資料載入中...

2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]